# Clinical Study to Evaluate the Body Fat Reducing Effect and Safety of GTB1

> **NCT06422013** · NA · COMPLETED · sponsor: **Amorepacific Corporation** · enrollment: 100 (actual)

## Conditions studied

- Body Fat

## Interventions

- **DIETARY_SUPPLEMENT:** GTB1
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT06422013
- **Lead sponsor:** Amorepacific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-28
- **Primary completion:** 2023-12-08
- **Final completion:** 2023-12-08
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2024-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06422013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06422013, "Clinical Study to Evaluate the Body Fat Reducing Effect and Safety of GTB1". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06422013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*